The Longevity Fund

Founded 2011
Founders Laura Deming

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 15
Rounds per year 1.20
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 5
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Life Science
Summary

The main office of represented VC is situated in the San Francisco. The company was established in North America in United States.

The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ALX Oncology, Decibel Therapeutics, Fauna Bio. Among the most popular fund investment industries, there are Content Discovery, Health Care.

The fund is generally included in 2-6 deals every year. The top activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2019. Opposing the other organizations, this The Longevity Fund works on 7 percentage points less the average amount of lead investments.

The current fund was established by Laura Deming. Besides them, we counted 1 critical employee of this fund in our database.

The usual cause for the fund is to invest in rounds with 9-10 partakers. Despite the The Longevity Fund, startups are often financed by Venrock, General Catalyst, Elad Gil. The meaningful sponsors for the fund in investment in the same round are General Catalyst, Elad Gil, Caffeinated Capital. In the next rounds fund is usually obtained by General Catalyst, Elad Gil, Caffeinated Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of The Longevity Fund:
Typical Co-investors
The Longevity Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after The Longevity Fund:

Funds with similar focus

Funds from United States, San Francisco
Funds with similar focus located in United States, San Francisco:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Apposite Capital United Kingdom, London
Asia West United States, Oyster Bay
ProQuest Investments United States, Princeton
Harvard Angel Group United States, Boston
MRW Enterprises LLC -
365.fintech Slovakia, District of Zvolen
SHINMEI Japan, Tokyo
Stableton Financial Switzerland, Zug
Panoramic Ventures United States, Atlanta
Invivo Capital Partners Spain, Barcelona
Asia West United States, Oyster Bay

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Ediscovery
EdTech
Education
Health Care
Training
1
$3M29 Apr 2021 Israel Tel Aviv District Tel Aviv-Yafo

Rubedo Life Sciences

Biotechnology
Health Care
1
$12M03 Dec 2020 California Sunnyvale United States

Wellth

Health Care
Information Technology
mHealth
Personal Health
1
$1M19 Jun 2020 California Los Angeles United States

Celevity

Biotechnology
Health Care
Life Science
Pet
1
$4M03 Jan 2020 United States, San Francisco

Fauna Bio

Biotechnology
Health Care
Hospital
Medical
1
$4M11 Apr 2019 Berkeley California United States

Artificial Intelligence
Biotechnology
Health Care
Life Science
Pharmaceutical
Software
1
$18M11 Dec 2018 California Palo Alto United States

UNITY Biotechnology

Biotechnology
Health Care
Medical
1
$55M19 Mar 2018 California United States

Artificial Intelligence
Biotechnology
Health Care
Life Science
Pharmaceutical
Software
1
$4M26 Feb 2018 California Palo Alto United States

Precision BioSciences

Biotechnology
Genetics
Health Care
Medical
1
$25M11 May 2015 Durham North Carolina United States
News
Loyal raises $27M, aims to give dog owners more time with their pets

– San Francisco startup Loyal raised $27m in Series A funding.
– The round was led by Khosla Ventures and included First Round Capital, Box Group, Collaborative Fund, The Longevity Fund and Lachy Groom.
– The company is building an animal pharmaceutical company that is developing therapeutics aimed at extending both lifespan and healthspan for dogs.

Review

  • No reviews are submitted yet.
Related media
Top 20 investors with the biggest sum of Seed funding rounds in Medical Service industry over the recent years
If you have found a spelling error or the data isn’t actual, please, notify us by selecting that text and pressing Ctrl+Enter. Read more
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent The Longevity Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: